605 related articles for article (PubMed ID: 32888876)
1. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?
Brandão TB; Gueiros LA; Melo TS; Prado-Ribeiro AC; Nesrallah ACFA; Prado GVB; Santos-Silva AR; Migliorati CA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):e45-e51. PubMed ID: 32888876
[TBL] [Abstract][Full Text] [Related]
2. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
[TBL] [Abstract][Full Text] [Related]
3. Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection.
Surboyo MD; Ernawati DS; Budi HS
Minerva Dent Oral Sci; 2021 Aug; 70(4):161-168. PubMed ID: 34269548
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 impact on oral health: A general view.
Parra-Ortega I; Rodriguez-Ortega D
Bol Med Hosp Infant Mex; 2021 Jan; 78(2):91-94. PubMed ID: 33497372
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting Enzyme 2 Specific Cell Subset Identification in Oral Tissues: A Need of the Hour in COVID-19 Research.
Sarode GS; Sarode SC; Gadbail AR; Gondivkar S; Sharma NK; Patil S
J Contemp Dent Pract; 2020 Dec; 21(12):1305-1306. PubMed ID: 33893249
[TBL] [Abstract][Full Text] [Related]
6. Oral manifestations of COVID-19: Brief review.
Paradowska-Stolarz AM
Dent Med Probl; 2021; 58(1):123-126. PubMed ID: 33590976
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of "the New Normal with COVID-19".
Imai K; Tanaka H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207046
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection of the oral cavity and saliva.
Huang N; Pérez P; Kato T; Mikami Y; Okuda K; Gilmore RC; Conde CD; Gasmi B; Stein S; Beach M; Pelayo E; Maldonado JO; Lafont BA; Jang SI; Nasir N; Padilla RJ; Murrah VA; Maile R; Lovell W; Wallet SM; Bowman NM; Meinig SL; Wolfgang MC; Choudhury SN; Novotny M; Aevermann BD; Scheuermann RH; Cannon G; Anderson CW; Lee RE; Marchesan JT; Bush M; Freire M; Kimple AJ; Herr DL; Rabin J; Grazioli A; Das S; French BN; Pranzatelli T; Chiorini JA; Kleiner DE; Pittaluga S; Hewitt SM; Burbelo PD; Chertow D; ; ; Frank K; Lee J; Boucher RC; Teichmann SA; Warner BM; Byrd KM
Nat Med; 2021 May; 27(5):892-903. PubMed ID: 33767405
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A
Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713
[TBL] [Abstract][Full Text] [Related]
12. Covid-19 and oral diseases: Crosstalk, synergy or association?
Brandini DA; Takamiya AS; Thakkar P; Schaller S; Rahat R; Naqvi AR
Rev Med Virol; 2021 Nov; 31(6):e2226. PubMed ID: 33646645
[TBL] [Abstract][Full Text] [Related]
13. Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review.
Salas Orozco MF; Niño-Martínez N; Martínez-Castañón GA; Patiño Marín N; Sámano Valencia C; Dipp Velázquez FA; Sosa Munguía PDC; Casillas Santana MA
Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070998
[No Abstract] [Full Text] [Related]
14. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
Wu T; Zhang H; Hu E; Ma J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19.
Hao M; Wang D; Xia Q; Kan S; Chang L; Liu H; Yang Z; Liu W
Front Immunol; 2022; 13():879792. PubMed ID: 35860279
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
17. Oral manifestations of Covid-19-A literature review.
Farid H; Khan M; Jamal S; Ghafoor R
Rev Med Virol; 2022 Jan; 32(1):e2248. PubMed ID: 34028129
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
19. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
20. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
